Florida Cancer Specialists

Orlando, Florida 32806

We've found

1 trials

at this facility

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Orlando, FL

Use our guide to learn which trials are right for you!